OBSIDIAN

Welcome to the Brand page for “OBSIDIAN”, which is offered here for Pharmaceutical preparations in the field of gene therapy for the prevention and treatment of cardio-vascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculo-skeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, and gastroenterological disorders;.

Its status is currently believed to be active. Its class is unavailable. “OBSIDIAN” is believed to be currently owned by “Obsidian Therapeutics”.